Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
US Department of Justice
Novartis
Fish and Richardson
Queensland Health
Cipla
QuintilesIMS
Deloitte
Farmers Insurance

Generated: October 17, 2017

DrugPatentWatch Database Preview

ROXYBOND Drug Profile

« Back to Dashboard

Which patents cover Roxybond, and when can generic versions of Roxybond launch?

Roxybond is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. There is one patent protecting this drug.

This drug has nineteen patent family members in eight countries and one supplementary protection certificate in one country.

The generic ingredient in ROXYBOND is oxycodone hydrochloride. There are seventeen drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.

Summary for Tradename: ROXYBOND

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROXYBOND at DailyMed

Pharmacology for Tradename: ROXYBOND

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi Sankyo Inc
ROXYBOND
oxycodone hydrochloride
TABLET;ORAL209777-001Apr 20, 2017RXNoNo► Subscribe► SubscribeY ► Subscribe
Daiichi Sankyo Inc
ROXYBOND
oxycodone hydrochloride
TABLET;ORAL209777-002Apr 20, 2017RXNoNo► Subscribe► SubscribeY ► Subscribe
Daiichi Sankyo Inc
ROXYBOND
oxycodone hydrochloride
TABLET;ORAL209777-003Apr 20, 2017RXNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ROXYBOND

Country Document Number Estimated Expiration
China105534936► Subscribe
Australia2009282376► Subscribe
Japan2016138126► Subscribe
World Intellectual Property Organization (WIPO)2009023672► Subscribe
Canada2696341► Subscribe
World Intellectual Property Organization (WIPO)2010019279► Subscribe
BrazilPI0815387► Subscribe
European Patent Office2187873► Subscribe
Australia2008286914► Subscribe
Japan2010536770► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: ROXYBOND

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Teva
Farmers Insurance
Novartis
Dow
Chinese Patent Office
UBS
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot